GLAXOSMITHKLINE PLC's ticker is GSK and the CUSIP is 37733W105. A total of 743 filers reported holding GLAXOSMITHKLINE PLC in Q1 2015. The put-call ratio across all filers is 1.95 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $2,293,000 | -0.3% | 52,696 | -0.2% | 0.82% | +13.8% |
| Q1 2022 | $2,300,000 | -1.4% | 52,810 | -0.2% | 0.72% | -3.6% |
| Q4 2021 | $2,332,000 | +6.2% | 52,896 | -7.9% | 0.74% | +0.3% |
| Q3 2021 | $2,195,000 | -6.2% | 57,452 | -2.2% | 0.74% | -1.1% |
| Q2 2021 | $2,340,000 | +18.2% | 58,771 | +6.0% | 0.75% | +12.3% |
| Q1 2021 | $1,979,000 | -3.4% | 55,459 | -0.4% | 0.67% | -10.1% |
| Q4 2020 | $2,049,000 | +31.1% | 55,690 | +34.1% | 0.74% | +10.5% |
| Q3 2020 | $1,563,000 | +45.4% | 41,527 | +57.5% | 0.67% | +42.3% |
| Q2 2020 | $1,075,000 | +3.0% | 26,372 | -4.3% | 0.47% | -7.6% |
| Q1 2020 | $1,044,000 | -18.4% | 27,565 | +1.2% | 0.51% | +19.6% |
| Q4 2019 | $1,279,000 | +67.2% | 27,230 | +51.9% | 0.43% | +58.5% |
| Q3 2019 | $765,000 | +47.7% | 17,927 | +38.4% | 0.27% | +50.0% |
| Q2 2019 | $518,000 | -9.8% | 12,952 | -5.8% | 0.18% | -11.8% |
| Q1 2019 | $574,000 | +9.3% | 13,749 | 0.0% | 0.20% | -5.1% |
| Q4 2018 | $525,000 | -4.9% | 13,749 | 0.0% | 0.22% | +15.6% |
| Q3 2018 | $552,000 | +28.7% | 13,749 | +29.1% | 0.19% | +23.2% |
| Q2 2018 | $429,000 | +4.1% | 10,649 | +0.9% | 0.15% | +0.7% |
| Q1 2018 | $412,000 | -9.6% | 10,549 | -18.0% | 0.15% | -11.8% |
| Q4 2017 | $456,000 | -9.7% | 12,871 | +3.4% | 0.17% | -11.5% |
| Q3 2017 | $505,000 | -5.8% | 12,444 | 0.0% | 0.19% | -4.5% |
| Q2 2017 | $536,000 | +4.5% | 12,444 | +2.1% | 0.20% | +6.9% |
| Q1 2017 | $513,000 | +24.2% | 12,191 | +13.5% | 0.19% | +25.3% |
| Q4 2016 | $413,000 | -10.8% | 10,738 | +0.0% | 0.15% | -13.3% |
| Q3 2016 | $463,000 | -0.4% | 10,735 | +0.0% | 0.17% | -3.4% |
| Q2 2016 | $465,000 | +7.1% | 10,732 | +0.1% | 0.18% | +4.7% |
| Q1 2016 | $434,000 | -5.4% | 10,726 | -5.7% | 0.17% | -6.0% |
| Q4 2015 | $459,000 | +7.5% | 11,377 | +2.3% | 0.18% | +2.2% |
| Q3 2015 | $427,000 | -7.8% | 11,124 | +0.0% | 0.18% | +4.1% |
| Q2 2015 | $463,000 | -23.7% | 11,121 | -15.5% | 0.17% | -20.8% |
| Q1 2015 | $607,000 | +12.6% | 13,162 | +4.4% | 0.22% | +12.5% |
| Q4 2014 | $539,000 | +3.3% | 12,613 | +11.0% | 0.19% | +3.8% |
| Q3 2014 | $522,000 | -14.0% | 11,360 | +0.0% | 0.18% | -10.2% |
| Q2 2014 | $607,000 | -0.8% | 11,358 | -0.8% | 0.21% | -6.4% |
| Q1 2014 | $612,000 | +2.9% | 11,455 | +2.7% | 0.22% | -3.9% |
| Q4 2013 | $595,000 | +9.6% | 11,150 | +3.0% | 0.23% | +2.2% |
| Q3 2013 | $543,000 | +0.4% | 10,827 | 0.0% | 0.22% | -3.4% |
| Q2 2013 | $541,000 | – | 10,827 | – | 0.23% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Sio Capital Management, LLC | 325,823 | $11,557,000 | 6.52% |
| KAHN BROTHERS GROUP INC | 1,139,163 | $40,406,111,000 | 6.35% |
| Chubb Ltd | 400,000 | $14,188,000 | 6.18% |
| Healthcare Value Capital, LLC | 50,000 | $1,774,000 | 5.40% |
| CLARK ESTATES INC/NY | 650,000 | $23,056,000 | 3.81% |
| PVG ASSET MANAGEMENT CORP | 220,450 | $7,819,361,000 | 3.57% |
| Martin Capital Partners, LLC | 88,195 | $3,128,000 | 3.25% |
| Camber Capital Management LP | 1,500,000 | $53,205,000 | 2.60% |
| EQUITY INVESTMENT CORP | 2,090,120 | $74,137,000 | 2.47% |
| Keystone Financial Planning, Inc. | 129,102 | $4,579,000 | 2.44% |